Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Buprenorphine 16mg / Naloxone 4mg sublingual tablets sugar free |
BNF code | 0410030B0AAACAC |
Virtual Therapeutic Moiety | Buprenorphine + Naloxone |
Abbreviated name | Buprenorphine 16mg / Naloxone 4mg sublingual tab sugar free |
Basis of preferred name | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✓ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Naloxone hydrochloride dihydrate |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 372890007 |
Strength value numerator | 4.000 |
Strength value numerator unit | mg |
Virtual Product Ingredient | |
Ingredient | Buprenorphine hydrochloride |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 387173000 |
Strength value numerator | 16.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tabletsublingual.oromucosal |
Dose Form | |
Formulation | Sublingual tablet |
Drug Route | |
Route | Sublingual |
Controlled Drug Prescribing Information | |
Controlled Drug category | Schedule 3 (CD No Register) |
Actual Medicinal Products | |
Suboxone 16mg/4mg sublingual tablets (Indivior UK Ltd) | |
Virtual Medicinal Product Packs | |
Buprenorphine 16mg / Naloxone 4mg sublingual tablets sugar free 28 tablet |
dm+d data retrieved from TRUD: release NHSBSA_10.3.0_20241028000001, imported on 29th October 2024 at 03:59:29.